Paul Szauter, PhD, Chief Scientific Officer, EquiSeq – Page 2

Experienced Equestrian Joins EquiSeq Board

Albuquerque, New Mexico, USA June 20, 2025 EquiSeq, a leader in developing genetic tests for horses, is pleased to announce the appointment of Madison R. Sanders to its Board of Directors, effective immediately. Ms. Sanders is an experienced equestrian with a proven track record in sales and marketing. She is a lifelong hunter/jumper equestrian and…

Science Team Meets to Discuss Projects

Four members of EquiSeq’s Scientific Advisory Board. Left to right: David Nannemann, Paul Szauter, Jesse Young, and Jeremy Edwards. Four members of EquiSeq’s Scientific Advisory Board met on June 2 to get acquainted and to discuss ongoing research projects. Science team members Jeremy Edwards (University of New Mexico), Jesse Young (TriCore Reference Laboratories), David Nannemann…

P4 Allele of MYOZ3

Introduction This blog post explores the P4 allele (S42L) of the equine MYOZ3 gene, which encodes myozenin 3. Portions of this blog post serve as additional sources of information to supplement the MYOZ3 Gene Page. We present data to support the hypothesis that the P4 allele of MYOZ3 (S42L) is damaging. The substitution of leucine…

P2 Allele of MYOT

Introduction This blog post explores the P2 allele (S232P) of the equine MYOT gene, which encodes myotilin. Portions of this blog post serve as additional sources of information to supplement the MYOT Gene Page. We present data to support the hypothesis that the P2 allele of MYOT (S232P) is damaging. The substitution of proline (heterocyclic)…

Twenty European countries issue patent on EquiSeq DNA tests

ALBUQUERQUE, NEW MEXICO EquiSeq announced today that a group of twenty countries in Europe have issued a patent on EquiSeq’s DNA test for three genetic variants that predispose to muscle disease. The tests are part of EquiSeq’s current DNA panel. Test results allow horse owners to better manage affected horses, and can be used to…

Jeremy Edwards speaks on intellectual property

Jeremy Edwards, Chair of Department of Chemistry and Chemical Biology at the University of New Mexico, is one of UNM’s most prolific inventors. Dr. Edwards is part of the EquiSeq science team and is an inventor on two of EquiSeq’s patents. In this interview, Dr. Edwards talks about the importance of protecting intellectual property.

South Africa issues patent on EquiSeq DNA tests

ALBUQUERQUE, NEW MEXICO EquiSeq announced today that South Africa has issued a patent on EquiSeq’s DNA tests for three genetic variants in horses that predispose to muscle disease. The tests are part of EquiSeq’s current DNA panel. Test results allow horse owners to better manage affected horses, and can be used to improve a breeding…

New Zealand issues patent on EquiSeq DNA tests

ALBUQUERQUE, NEW MEXICO EquiSeq announced today that New Zealand has issued a patent on EquiSeq’s DNA tests for three genetic variants in horses that predispose to muscle disease. The tests are part of EquiSeq’s current DNA panel. Test results allow horse owners to better manage affected horses, and can be used to improve a breeding…

Canada issues patent on EquiSeq DNA tests

ALBUQUERQUE, NEW MEXICO EquiSeq announced today that Canada has issued a patent on EquiSeq’s DNA tests for three genetic variants in horses that predispose to muscle disease. The tests are part of EquiSeq’s current DNA panel. Test results allow horse owners to better manage affected horses, and can be used to improve a breeding program…

Genes First!

EquiSeq has released a major revision to the software that powers our website and database. We now present genetic test results starting with the affected gene. Here is an example of the appearance of the new horse profile pages. Figure 1. A horse profile page returning results from EquiSeq. This horse has tested positive for the…